Innocan Pharma Corporation has announced a partnership with Freedom Farm to support rescued animals suffering from painful conditions. This collaboration allows animals at the sanctuary to receive treatment with Innocan's LPT-CBD injection, significantly improving their quality of life and alleviating pain.
Quick answer
Innocan Pharma Partners with Freedom Farm to Provide Pain Relief for Rescued Animals Using LPT-CBD Injection. (September 18, 2025). INNOCAN PHARMA Corp is based in Herzliya, Tel Aviv, Israel.
What agreement did INNOCAN PHARMA Corp announce on September 18, 2025?
Innocan Pharma Corporation has announced a partnership with Freedom Farm to support rescued animals suffering from painful conditions. This collaboration allows animals at the sanctuary to receive treatment with Innocan's LPT-CBD injection, significantly improving their quality of life and alleviating pain.
What does INNOCAN PHARMA Corp do?
Innocan is a pharmaceutical tech company that operates under two main segments: Pharmaceuticals and Consumer Wellness.
Where is INNOCAN PHARMA Corp based?
INNOCAN PHARMA Corp is based in Herzliya, Tel Aviv, Israel.
Source: Fundz verified event record.
Company Information
Company
INNOCAN PHARMA Corp
Location
1015, 926 - 5 AVENUE SW
Herzliya, Tel Aviv, Israel
About
Innocan is a pharmaceutical tech company that operates under two main segments: Pharmaceuticals and Consumer Wellness. In the Pharmaceuticals segment, Innocan focuses on developing innovative drug delivery platform technologies comprises with cannabinoids science, to treat various conditions to improve patients' quality of life. This segment involves two drug delivery technologies: (i) LPT CBD- loaded liposome platform facilitating exact dosing and the prolonged and controlled release of CBD into the blood stream. The LPT delivery platform research is in the preclinical trial phase for two indications: Epilepsy and Pain Management. (ii) CLX CBD-loaded exosomes platform that may hold the potential to provide a highly synergistic effect of regenerating and anti- inflammatory properties targeting the Central Nervous System (CNS). In the Consumer Wellness segment, Innocan develops and markets a wide portfolio of innovative and high-performance self-care products to promote a healthier lifestyle. Under this segment Innocan has established a Joint Venture by the name of BI Sky Global Ltd. that focuses developing on advanced targeted online sales. https://innocanpharma.com/